The human brain needs a large amount of energy to function properly, and researchers at the University of Illinois have reported in a new study that the health of brain metabolism in young adults may predict fluid intelligence – the capacity to solve unusual logic-based problems in novel situations.
Data is at the crux of today’s biological research and the potential of big data in scientific...
Bioscience Technology spoke with Neurophysiologist Stephen Morairty, Ph.D., of SRI...
Early metastatic breast cancer cells are, strikingly, far more like stem cells than other tumor...
Researchers from Cold Spring Harbor Laboratory have discovered a new growth-regulating pathway in plants that has eluded scientists for years. In addition, by tweaking this new pathway the scientists have found a way to gently upregulate stem cell growth, boosting maize’s yield by up to 50 percent, which could have important real-world applications.
While many industries are blazing new trails in pursuit of new technologies, pharma appears to be lagging behind, often adopting a watch and wait approach. In most industries, the pace of technology change has increased so much that corporate IT leaders who don't embrace emerging trends end up behind the competition and eventually out of business. Can we really say the same is true for pharma companies?
Surface Plasmon Resonance (SPR) and phage display are both techniques that are well suited to high-throughput environments. In particular, phage display has found utility in antibody production. SPR has been explored as a means of substantially reducing the time and number of steps required for phage antibody isolation, while simultaneously providing kinetics and affinity information that are the hallmarks of the SPR technique.
Advances in technology are pushing the limits of sample throughput for qPCR, ELISAs, and many other core biological assays. This has the potential to greatly improve lab efficiency but also create process bottlenecks if not managed correctly. With the proper tools, scientists can tackle the greater number of samples and the levels of repetition this sample processing requires, while ensuring reproducibility of their results.
Jennifer Doudna, Ph.D., one of the brains behind the revolutionary CRISPR-Cas9 gene editing technology told Bioscience Technology about her early exploration into science and where she thinks CRISPR will have the biggest impact.
Recently, some have begun to explore the utilization of the crowd for various purposes in medical research, including fundraising as well as crowdsourcing for intellectual analyses and insights.
Digging through volumes of pharmaceutical data in any form, be that of lab reports, experimental results, clinical trial reports, scientific publications, patent filings, to even emails is a gargantuan task. The data may deal with diseases, genes, drugs, active agents and mechanisms of action and can be textual, structured data like molecule structures, formulae, SAS data sets from clinical trials, curves, diagrams, and more.
Melting snow ice and glaciers in Europe, changes to the terrestrial ecosystem in Asia, and wildfires in the state of Alaska.
Academic researchers work on average more than 60 hours per week, according to a Inside Higher Ed survey. Why? Many scientists feel the sacrifice is worth it, as they devote their lives to an overwhelmingly important and meaningful human pursuit. Why then would researchers jeopardize the legitimacy of their work over results that could be potentially irreproducible?
Scientists recently converged in Philadelphia for the American Epilepsy Society’s (AES) 69th Annual Meeting, touting new studies and insights in the field of epilepsy. Researchers discussed new findings, including personalized medicine, and the promise of Cannabidiol in human and animal studies.
Object storage has been around for some time, but the technology is now gaining more and more traction in life sciences. This article outlines six reasons that organizations should add object storage to their genomics lexicon.
Michael Zigman, founder of i2 Learning and friend Ethan Berman, a technology entrepreneur formerly with JP Morgan, launched a highly innovative, hands-on STEM (science, technology, engineering, math) summer program in 2013 for middle schoolers in two empty schools. The i2 crew decided to expand into the school day.
Precision cancer medicine is driven by the latest advances in genetic technologies. In light of falling costs and increased accessibility sparking a greater uptake of next generation sequencing (NGS), Clinical Scientists Dr. Matthew Smith and Dr. George Burghel discussed the strengths and challenges of this approach.
For an intense global program called 1000 Girls-1000 Futures, the NYAS recently sought 60 women willing to devote a full year to mentees from Mexico alone. NYAS head Ellis Rubenstein told the presser Mexican supporters were “terrified” no one would step up. But 170 woman researchers—and counting— stepped up worldwide.
Lyophilization, also known as freeze-drying, is a critical technology for the food industry, pharmaceuticals and biotech. However, the process, which removes water from products at low temperatures and low pressure, is expensive, time-consuming and has remained unchanged for the last 50 years.